Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-11-08
2005-11-08
Celsa, Bennett (Department: 1639)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S019300, C514S557000, C514S558000, C514S825000, C514S886000, C514S400000, C514S563000, C530S300000, C530S324000, C562S450000
Reexamination Certificate
active
06962899
ABSTRACT:
Pharmaceutically acceptable compounds for administering to a subject, comprising the general structure II:wherein R1is an L-amino acid or salt or ester thereof, or an L-amino acid containing peptide or salt or ester thereof; and wherein the stereochemistry about the carbon-carbon double bond is trans. The invention further relates to pharmaceutical compositions comprising the aforementioned compounds.
REFERENCES:
Ogonowski et al., J. Pharm. And Experimental Therapeutics vol. 280, No. 2 (1997) pp. 846-853.
Ping et al. J. Biol. Chem. vol. 270, No. 49 (Dec. 1995) pp. 29250-29255.
Katopodis et al., Biochemistry vol. 29 (1990) pp. 4541-4548.
Ogonowski et al., FASEB J. vol. 9, No. 4, p. A956, Apr. 1995.
Bundgaard, Design of Prodrugs (Elsevier Publishing) Ch. 1 pp. 1-10, 1985.
Matucci-Cerinice et al.: “The Contribution of the peripheral nervous system and the neuropeptide network to the development of synovial inflammation.” Clinical and Experimental Rheumatology 10:pp. 211-215, 1992.
Panagakos et al. “Modulation of Carrageenan-Induced Hind Paw Edema by Substance P.” Inflammation, vol. 18, No. 3, pp 285-292, 1994.
Bradbury, A.F., Finnie, M.D.A. and Smyth, D.G.: Mechanism of C-terminal amide formation by pituitary enzymes. Nature 298: 686-688, 1982.
Colpaert, F.C., Donner, J. and Lembeck, F.: Effects of capsaicin on inflammation and on the substance P content of nervous tissue in rate with adjuvant arthritis. Life Sci. 32: 1827-1834, 1983.
Cronstein, B.N. and Weissmann, G.: Targets for antiinflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 35: 449-462, 1995.
DiRosa, M., Giroud, J.P. and Willoughby, D.A.: Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Pathol 104: 15-29, 1971.
Doherty, N.S., Beaver, T.H., Chan, K.Y., Coutant, J.E. and Westrich, G.L.: The role of prostaglandins in the nociceptive response induced by intraperitoneal injection of zymosan in mice. Br. J. Pharmacol. 91: 39-47, 1987.
Dray, A. and Perkins, M.: Bradykinin and inflammatory pain. Trends Neurosci. 61: 99-104, 1993.
Gamse, R.: Capsaicin and nociception in the rat and mouse. Possible role of substance. P. Naunyn-Schmiedeberg Arch. Pharmacol. 320: 205-216, 1982, p206.
Garry, M.G. and Hargreaves, K.M.: Enhanced release of immunoreactive CGRP and substance P from spinal dorsal horn slices occurs during carrageenan inflammation. Brain Res. 582: 139-142, 1992.
Iadarola, M.J. and Draisci, G.: Elevation of spinal cord dynorphin mRNA compared to dorsal root ganglion peptide mRNAs during peripheral inflammation. In The Arthritic Rat as a Model of Clinical Pain? ed. by J.M. Beeson and G. Guilbaud, pp. 173-183, Elsevier, Armsterdam, 1988.
Katopodis, A.G. and May, S.W.: Novel substrates and inhibitors of peptidylglycine .alpha.-amidating monooxygenase. Biochemistry 29: 4541-4548, 1990.
Katopodis, A.G., Ping, D. and May, S.W.: A Novel enzyme from bovine neurointermediate pituitary catalyzes dealkylation of .alpha.-hydroxyglycine derivatives, thereby functioning sequentially with peptidylglycine .alpha.-amidating monooxygenase in peptide amidation. Biochemistry 29: 6115-6120, 1990.
Katopodis, A.G., Ping, D., Smith C.E. and May, S.W.: Functional and structural characterization of peptidylamidogylocate lyase, the enzyme catalyzing the second step in peptide amidation. Biochemistry 30: 6189-6194, 1991.
Lam, F.Y. and Ferrell, W.R.: Neurogenic component of different models of acute inflammation in the rat knee joint. Ann. Rheum. Dis. 50: 747-751, 1991.
Levine, J.D., Clark, R., Devor, M., Helmes, C., Moskowitz, M.A. and Basbaum, A. I.: Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226: 547-549, 1984.
Li, C., Oldham, C.D. and May, S.W., NN-Dimethyl-1,4-phenylenediamine as an alternative reductant for peptidylglycine .alpha.-amidating mono-oxygenase catalysis. Biochem. J. 300: 31-36, 1994.
Oldham, C.D., Li, C., Girard, P.R., Nerem, R.M. and May, S.W.: Peptide amidating enzymes are present in cultured endothelian cells. Biochem. Biophys. Res. Commun. 184: 323-329, 1992.
Ping, D., Mounier, C.E. and May, S.W.: Reaction versus subsite stereospecificity of peptidyglycine .alpha.-monooxygenase and peptidylamidoglycolate lyase, the two enzymes involved in peptide amidation. J. Biol. Chem. 270: 29250-29255, 1995.
Smith, G., Harrison, S., Bowers, J., Weisman, J. and Birch, P.: Non-specific effects of the tachykinin NK.sub.1 receptor anatagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. Eur. J. Pharmacol. 271: 481-487: 1994.
Tissot, M., Pradelles, P. and Giroud, J.P.: Substance-P-like levels in inflammatory exudates. Inflammation 12: 25-35, 1988.
Vinegar, R., Truax, J.F., Selph, J.L., Johnston, P.R., Venable, A.L. and McKenzie, K.K.: Pathway to carrageenan-induced inflammation in the hind limb of the rat. Fed. Proc. 46: 118-126, 1987.
Ogonowski, A.A., May, S.W., Moore, A.B., Barrett, L.T., O Bryant, C.L., Pollock, S.H.: Antiinflammatory and analgesic activity of an infibitor of neuropeptide amidation. Journal of Pharmacological and Experimental Therapeutics 280: 846-853, 1997.
Bradbury, A.F., Mistry, J., Roos, B.A. and Smyth, D.G.: 4-Phenyl-3-butenoic acid an in vivo inhibitor of peptidylglycine hyrdroxylase (peptide amidating enzyme). Eur. J. Biochem. 189: 363-368, 1990.
Eipper, B.A., Stoffers, D.A. and Mains, R.E.: The biosynthesis of neuropeptides: Peptide .alpha.-amidation. Annu. Rev. Neurosci. 15: 57-85, 1992.
Meuller, G.P., Husten, E.J., Mains, R.E. and Eipper, B.A.: Peptide .alpha.-hydroxylation monooxygenase: control by disulfiram. Mol. Pharmacol. 44: 972-980, 1993.
Gilligan et al. Modulation of carrageenan-induced hind paw edema by substance p. Inflammation. 18(3) :285-292, 1994.
May Sheldon W.
Pollock Stanley H.
Celsa Bennett
Georgia Tech Research Corporation
Mercer University
Needle & Rosenberg P.C.
LandOfFree
Method for reducing the inflammation and inducing an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing the inflammation and inducing an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing the inflammation and inducing an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3489989